Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Pavoni

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Scandinavian Journal of Gastroenterology|April 25, 2018
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016Giulia Fiorini, Angelo Zullo, Ilaria Maria Saracino, et al.
Internal and Emergency Medicine|March 22, 2020
Efficacy of a new nutraceutical formulation (CHETOGERD<sup>®</sup>) in patients with nonerosive reflux disease (NERD): a prospective observational studyGiulia Fiorini, Ilaria Maria Saracino, Matteo Pavoni, et al.
Antibiotics (Basel, Switzerland)|January 17, 2020
Trends in Primary Antibiotic Resistance in <i>H. pylori</i> Strains Isolated in Italy between 2009 and 2019Ilaria Maria Saracino, Giulia Fiorini, Angelo Zullo, et al.
European Journal of Gastroenterology & Hepatology|February 27, 2018
Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practiceGiulia Fiorini, Angelo Zullo, Ilaria M Saracino, et al.
Helicobacter|November 3, 2017
Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori -resistant strainsGiulia Fiorini, Ilaria Maria Saracino, Angelo Zullo, et al.
Antibiotics (Basel, Switzerland)|January 21, 2022
Antifungal Activity of Natural Compounds vs. <i>Candida</i> spp.: A Mixture of Cinnamaldehyde and Eugenol Shows Promising In Vitro ResultsIlaria Maria Saracino, Claudio Foschi, Matteo Pavoni, et al.
The Journal of Antimicrobial Chemotherapy|November 27, 2018
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradicationVincenzo De Francesco, Angelo Zullo, Giulia Fiorini, et al.
Antibiotics (Basel, Switzerland)|April 30, 2021
Next Generation Sequencing for the Prediction of the Antibiotic Resistance in <i>Helicobacter pylori</i>: A Literature ReviewIlaria Maria Saracino, Matteo Pavoni, Angelo Zullo, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|January 14, 2020
Efficacy of a New Nutraceutical Formulation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a Prospective Observational StudyFerdinando D'Amico, Giulia Fiorini, Antonio Tursi, et al.
Viruses|October 26, 2021
Feasibility and Effectiveness Assessment of SARS-CoV-2 Antigenic Tests in Mass Screening of a Pediatric Population and Correlation with the Kinetics of Viral LoadsMarcello Lanari, Giovanni Battista Biserni, Matteo Pavoni, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Scandinavian Journal of Gastroenterology|April 25, 2018
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016Giulia Fiorini, Angelo Zullo, Ilaria Maria Saracino, et al.
Internal and Emergency Medicine|March 22, 2020
Efficacy of a new nutraceutical formulation (CHETOGERD<sup>®</sup>) in patients with nonerosive reflux disease (NERD): a prospective observational studyGiulia Fiorini, Ilaria Maria Saracino, Matteo Pavoni, et al.
Antibiotics (Basel, Switzerland)|January 17, 2020
Trends in Primary Antibiotic Resistance in <i>H. pylori</i> Strains Isolated in Italy between 2009 and 2019Ilaria Maria Saracino, Giulia Fiorini, Angelo Zullo, et al.
European Journal of Gastroenterology & Hepatology|February 27, 2018
Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practiceGiulia Fiorini, Angelo Zullo, Ilaria M Saracino, et al.
Helicobacter|November 3, 2017
Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori -resistant strainsGiulia Fiorini, Ilaria Maria Saracino, Angelo Zullo, et al.
Antibiotics (Basel, Switzerland)|January 21, 2022
Antifungal Activity of Natural Compounds vs. <i>Candida</i> spp.: A Mixture of Cinnamaldehyde and Eugenol Shows Promising In Vitro ResultsIlaria Maria Saracino, Claudio Foschi, Matteo Pavoni, et al.
The Journal of Antimicrobial Chemotherapy|November 27, 2018
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradicationVincenzo De Francesco, Angelo Zullo, Giulia Fiorini, et al.
Antibiotics (Basel, Switzerland)|April 30, 2021
Next Generation Sequencing for the Prediction of the Antibiotic Resistance in <i>Helicobacter pylori</i>: A Literature ReviewIlaria Maria Saracino, Matteo Pavoni, Angelo Zullo, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|January 14, 2020
Efficacy of a New Nutraceutical Formulation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a Prospective Observational StudyFerdinando D'Amico, Giulia Fiorini, Antonio Tursi, et al.
Viruses|October 26, 2021
Feasibility and Effectiveness Assessment of SARS-CoV-2 Antigenic Tests in Mass Screening of a Pediatric Population and Correlation with the Kinetics of Viral LoadsMarcello Lanari, Giovanni Battista Biserni, Matteo Pavoni, et al.
Pageof 5